The BEACON Study (Breast Cancer Outcomes With NKTR-102)
Completed · Phase 3
Conditions studied: Locally Recurrent Breast Cancer, Metastatic Breast Cancer
In brief
The study is designed as an open-label, randomized, parallel, two arm, multicenter, international Phase 3 study in patients with recurrent or metastatic breast cancer previously treated with cytotoxic chemotherapy regimens. The primary study objective is to compare overall survival of patients who receive NKTR-102 given once every 21 days to patients who receive treatment of Physician's Choice selected from a list of seven single-agent intravenous therapies.
Key facts
- Study ID
- NCT01492101
- Run by
- Nektar Therapeutics
- People needed
- 852
- Starts
- 2011-12-01
- Expected to finish
- 2016-06-01
- Last updated by the study team
- 2021-06-01
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Providence Health System - Southern California d/b/a Roy and Patricia Disney Family Cancer Center — Burbank, California, United States
- University of Southern California — Los Angeles, California, United States
- PMK Medical Group, Inc., DBA Ventura County Hematology Oncology Specialists — Oxnard, California, United States
- Wilshire Oncology Medical Group, Inc. — Pasadena, California, United States
- Desert Hematology Oncology Medical Group — Rancho Mirage, California, United States
- University of California San Francisco — San Francisco, California, United States
- Stanford University School of Medicine — Stanford, California, United States
- Kaiser Permanente — Vallejo, California, United States
- Rocky Mountain Cancer Centers — Denver, Colorado, United States
- Pre clinical Science Bldg LR3 — Washington D.C., District of Columbia, United States
- Medstar — Washington D.C., District of Columbia, United States
- Mayo Clinic in Florida — Jacksonville, Florida, United States
- University of Miami School of Medicine — Miami, Florida, United States
- Advanced Medical Specialties — Miami, Florida, United States
- Florida Cancer Research Institute — Plantation, Florida, United States
- Hematology Oncology Associates of the Treasure Coast — Port Saint Lucie, Florida, United States
- Northeast Georgia Cancer Care — Athens, Georgia, United States
- Peachtree Hematology Oncology Consultants — Atlanta, Georgia, United States
- Emory University — Atlanta, Georgia, United States
- Central Georgia Cancer Care — Macon, Georgia, United States
- Northwest Georgia Oncology Centers, P.C. — Marietta, Georgia, United States
- Summit Cancer Care, P.C. — Savannah, Georgia, United States
- The University of Chicago Medicine — Chicago, Illinois, United States
- Oncology Specialists — Niles, Illinois, United States
- Arizona Oncology Associates, PC - NAHOA — Flagstaff, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.